Home / Peptide legality / Mississippi
Are peptides legal in Mississippi?
Mississippi restricts clinical peptide access: FDA-approved GLP-1 medicines such as Wegovy® (semaglutide) remain legal with a valid prescription, but state licensing boards have jointly prohibited licensed providers from prescribing, compounding, or recommending non-FDA-approved research-grade peptides like BPC-157 and TB-500.
Legal status overview
Mississippi restricts clinical peptide access even though it has no peptide-specific statute. FDA-approved GLP-1 medicines like Ozempic® (semaglutide) and Wegovy® (semaglutide) are legal when prescribed by a licensed provider, while unapproved research peptides sit in a gray zone for personal possession but are off-limits inside the licensed healthcare system. A 2026 joint statement from the state's medical, nursing, and pharmacy boards bars licensed providers from supplying research-grade peptides to patients, and patient consent forms do not shield a provider from liability. The Mississippi Board of Pharmacy has separately warned that compounded semaglutide salt formulations may not meet federal bulk-substance standards and can trigger enforcement.
Key points
- Mississippi has no statute or Board of Pharmacy rule that treats peptides or research chemicals as a distinct legal class, so status is set by federal drug law plus the state's general pharmacy and prescription rules. [4]
- A 2026 joint statement by Mississippi's medical, nursing, and pharmacy boards prohibits licensed providers from compounding, administering, dispensing, prescribing, recommending, or supplying non-FDA-approved research-grade peptides to patients. [4]
- The boards acknowledged patients may independently obtain and self-administer such products, but stated that consent forms do not protect a provider from liability. [4]
- The Mississippi Board of Pharmacy has warned licensees that compounding semaglutide does not meet FDA requirements and may result in enforcement action, noting only semaglutide base (not salt forms) appears on the FDA-approved products list and semaglutide has no USP or NF monograph. [1]
- Under Section 503A, a compounded drug is exempt from standard new-drug approval only when made by a licensed pharmacist for an identified patient under a valid prescription; compounded medicines are not FDA-approved, are not a generic, and are not evaluated by the FDA. [2]
- The FDA placed BPC-157 in Category 2 of the 503A bulk drug substances evaluation in 2023 over immunogenicity and impurity concerns, and although it was removed from Category 2 in April 2026, removal is not Category 1 approval and does not make it eligible for lawful compounding. [3]
- FDA-approved growth hormone (somatropin) is prescription-only; federal law at 21 U.S.C. 333(e) makes distribution for non-approved uses such as anti-aging or bodybuilding a felony. [4]
Compound-by-compound status
| BPC-157 Restricted | Unapproved drug with no FDA-approved product; covered by the Mississippi boards' research-grade peptide prohibition, so no lawful clinical pathway exists in the state. Sold only through a research-use-only retail channel not intended for human use. |
|---|---|
| GLP-1 class (Wegovy® (semaglutide), Ozempic® (semaglutide), Zepbound® (tirzepatide), Mounjaro® (tirzepatide)) Legal By Prescription | Brand-name FDA-approved products are legal with a valid prescription. Compounded semaglutide is not FDA-approved, is not a generic, and is not evaluated by the FDA, and the Board of Pharmacy warns salt-form compounding may trigger enforcement. |
| TB-500 (thymosin beta-4 fragment) Restricted | Unapproved drug with no FDA-approved product; falls under the state boards' research-grade peptide prohibition for licensed providers. Not lawfully marketable for human use. |
| Growth hormone / somatropin (e.g., Genotropin® (somatropin)) Legal By Prescription | FDA-approved somatropin is prescription-only for approved indications; federal law criminalizes distribution for non-approved uses. No Mississippi-specific rule; status set by federal prescription and controlled-substance law. |
Frequently asked questions
Are peptides legal in Mississippi?
There is no Mississippi law naming peptides as a category. FDA-approved products like Wegovy® (semaglutide) are legal by prescription, while unapproved research peptides such as BPC-157 have no lawful clinical pathway and licensed providers are barred from supplying them. This is information, not legal or medical advice.
Can a Mississippi clinic prescribe BPC-157?
No. A 2026 joint statement from the state's medical, nursing, and pharmacy boards prohibits licensed providers from prescribing, compounding, administering, or recommending non-FDA-approved research-grade peptides to patients.
Is compounded semaglutide allowed in Mississippi?
The Mississippi Board of Pharmacy has warned that compounding semaglutide does not meet FDA requirements and may result in enforcement. Compounded semaglutide is not FDA-approved, is not a generic, and is not evaluated by the FDA.
Do consent forms let a provider offer research peptides anyway?
No. The Mississippi boards specifically stated that patient consent forms do not shield a provider from liability for supplying non-FDA-approved research-grade peptides.
Is human growth hormone legal in Mississippi?
FDA-approved somatropin is legal only by physician prescription for approved indications. Federal law at 21 U.S.C. 333(e) makes distribution for anti-aging or bodybuilding a felony.
Sources
- Mississippi Board of Pharmacy: Semaglutide Compounding Guidance (retrieved 2026-09-21)
- FDA: Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act (retrieved 2026-09-21)
- FDA: Certain Bulk Drug Substances for Use in Compounding That May Present Significant Safety Risks (retrieved 2026-09-21)
- PeptideLaws.com: Mississippi Peptide Laws & Regulations (retrieved 2026-09-21)
Last researched: 2026-09-21.